Mode
Text Size
Log in / Sign up

Network meta-analysis of vital pulp therapy success in mature permanent teeth with carious exposureNew Study Reveals Which Fillings Actually Save Your Tooth

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider vital pulp therapy with calcium silicate materials for high success in mature teeth with carious exposure.

This is a network meta-analysis of randomized controlled trials evaluating vital pulp therapy for carious pulp exposure in mature permanent teeth, synthesizing data from 2906 teeth across 35 RCTs. The primary outcome was composite success (clinical and radiographic) at 6, 12, 24, and 36 months.

The authors found that success rates were generally comparable at >93% across all vital pulp therapy types and time points. For direct pulp caps and partial pulpotomy, MTA showed a greater likelihood of success than calcium hydroxide, and Biodentine also showed a greater likelihood of success than calcium hydroxide. No explicit difference was found between calcium silicate materials (e.g., MTA vs. Biodentine) due to overlapping credible intervals. Adjunctive therapies such as platelet-rich plasma and laser therapies showed a promising effect, but this was supported by low-certainty evidence based on limited data and network sparsity.

The network coherence met (p > 0.10) with low heterogeneity (τ² = 0.09). Key limitations noted by the authors include network sparsity for adjunctive therapies, limited data on adjunctive therapies, and overlapping credible intervals for comparisons among calcium silicate materials.

Practice relevance is that vital pulp therapy in mature permanent teeth demonstrates consistently high success rates, particularly with calcium silicate-based materials, providing decision-ready evidence supported by high-certainty evidence for comparisons with calcium hydroxide. However, the evidence for adjunctive therapies remains uncertain.

New Study Reveals Which Fillings Actually Save Your Tooth

When a Deep Cavity Becomes a Choice

Imagine sitting in the dentist’s chair, hearing the words no one wants: “The cavity is very deep, close to the nerve.” Suddenly, you’re facing a choice. Do you try to save the tooth with a special filling, or do you jump straight to a root canal or even an extraction?

For decades, dentists have used a procedure called vital pulp therapy to do just that—clean out the decay and place a protective dressing over the exposed nerve, hoping the tooth will heal itself. But which material works best? A massive new study analyzed years of research to find the answer.

Why Your Tooth’s Nerve Matters

Your tooth isn’t just hard enamel. Inside is a soft tissue called the pulp, which contains nerves and blood vessels. It’s the tooth’s life source.

When a cavity gets deep enough, it can expose this pulp, causing pain and inflammation. If the infection sets in, the traditional next step is a root canal, where the entire pulp is removed. While effective, this makes the tooth more brittle over time.

Vital pulp therapy aims to do the opposite: calm the nerve down and let it heal. It’s like putting a bandage on a deep cut instead of removing the whole limb. The goal is to keep the tooth alive and strong for years to come. But success depends heavily on the dressing material used.

The Old Guard vs. The New Wave

For years, the go-to material was calcium hydroxide, or Ca(OH)2. It was the classic choice, used by generations of dentists.

But it has a weakness. Over time, it can dissolve and create a gap between the material and the tooth, allowing bacteria to sneak back in and cause failure.

In recent years, a new class of materials has taken the stage: hydraulic calcium silicates. Think of brands like MTA (Mineral Trioxide Aggregate) and Biodentine. These are often called “bioactive” materials because they interact with the tooth’s environment to create a strong, lasting seal.

The big question has always been: Are these newer materials actually better, or just newer?

Think of an inflamed tooth nerve like a tiny, irritated factory that’s been exposed to the outside world. The goal is to calm the factory down so it can get back to work.

Calcium hydroxide acts like a strong chemical irritant. It shocks the tissue into creating a hard barrier, but it’s a bit like using a sledgehammer for a delicate job. The process can be harsh and the resulting barrier isn’t always perfect.

Calcium silicates, on the other hand, work more like a smart bandage. They are biocompatible, meaning the body accepts them well. They release minerals that encourage the tooth to build its own protective layer. They seal the area tightly, like a waterproof patch, preventing bacteria from causing more trouble. This gentle, sealing action is why scientists suspected they might be more effective.

What the Research Looked At

To settle the debate, researchers conducted a network meta-analysis. This is a powerful type of study that compares multiple treatments at once by analyzing all the high-quality randomized controlled trials on the topic.

They followed strict guidelines (PRISMA 2020) and searched six major medical databases. They focused on studies involving adult teeth with deep cavities that were either causing symptoms or not. In the end, they analyzed data from 24 high-quality studies, covering nearly 3,000 teeth.

The main question was simple: Which material led to the highest rate of "success" at 6, 12, 24, and 36 months? Success meant a tooth that was pain-free, functional, and showed no signs of infection on an X-ray.

The Clear Winner

The results were striking. Across the board, vital pulp therapy had a very high success rate—over 93%—regardless of the material used. That’s good news for anyone facing this procedure.

But when the researchers compared the materials head-to-head, a clear hierarchy emerged.

Hydraulic calcium silicates (MTA and Biodentine) were significantly more likely to succeed than the old standard, calcium hydroxide.

The evidence for MTA being better than calcium hydroxide was rated high certainty. For Biodentine vs. calcium hydroxide, it was moderate certainty. This means we can be very confident that these newer materials give your tooth a better fighting chance.

The Surprising Twist

Here’s where things get interesting. If MTA and Biodentine are both better than the old option, are they different from each other?

The study found the answer is no. When researchers compared MTA directly to Biodentine, their results were statistically indistinguishable. The evidence was rated as moderate certainty, meaning while they both beat the old guard, they appear to be equally effective rivals.

This doesn’t mean this treatment is available yet.

Researchers also looked at "adjunctive therapies"—extra treatments like platelet-rich plasma (PRP) or laser therapy applied during the procedure. The data suggested these might boost success rates even further, but the evidence was weak and based on very few studies. So, it’s an interesting area for future research, but not a proven recommendation yet.

What the Experts Are Saying

This analysis provides what the authors call "decision-ready evidence." For dentists, this is a significant shift. It strongly suggests that for the best outcomes in saving a mature permanent tooth, calcium silicate materials should be the first choice over calcium hydroxide.

The high certainty of the evidence for this comparison is key. In medicine, high-certainty evidence is the gold standard that clinical guidelines are built on. This study provides a solid foundation for that change.

What This Means for Your Next Dental Visit

If your dentist tells you that you need a deep filling or a pulpotomy, this research gives you a valuable talking point.

You can ask: "Are you using a calcium silicate material like MTA or Biodentine for this procedure?"

While these materials are already widely used in modern dentistry, this study confirms they offer a real advantage. It’s not about demanding a specific brand, but about understanding that the science points to this class of materials as the superior choice for protecting your tooth’s nerve.

A Note on the Research

This was a comprehensive and well-designed study. However, it’s important to know its limits. The analysis was based on combining data from many different studies, which can sometimes have variations. Also, while the main comparisons were strong, the data on extra therapies like lasers was too limited to draw firm conclusions.

This research provides a powerful new map for dentists and patients. The high success rates show that saving a damaged tooth nerve is a very reliable option. And now, we have high-certainty proof that using modern calcium silicate materials gives you the best odds.

For patients, this means more confidence in choosing a procedure that preserves their natural teeth. For the dental world, it’s a clear signal that the future of pulp therapy is already here—and it’s built on these advanced, bioactive materials.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
This network meta-analysis aimed to generate clinically credible, decision-ready evidence on the comparative effectiveness of bioactive materials used in vital pulp therapy (VPT) of mature permanent teeth with carious exposures, including symptomatic presentations. Following PRISMA 2020 and PRISMA-NMA standards (PROSPERO: CRD420251074110), randomized controlled trials evaluating full pulpotomy (FP), partial pulpotomy (PP), direct pulp capping (DPC), and indirect pulp capping (IPC) were systematically identified across six databases. The primary outcome was composite success (clinical and radiographic) at 6, 12, 24, and 36 months. Arm-based Bayesian random-effects network meta-analyses and frequentist sensitivity models (REML–Hartung–Knapp) were performed. Certainty of evidence was graded using CINeMA. The primary meta-analysis included a total of thirty-five RCTs with a total of 2906 teeth, of which a total of twenty-four RCTs involving mature/ permanent teeth were included. Success rates across all VPT types and time points of the 24 RCTs were generally comparable at >93%. Hydraulic calcium silicate materials (MTA & Biodentine) showed a greater likelihood of success than Ca(OH)2 in direct pulp caps and partial pulpotomy procedures. The difference was established with high-certainty evidence for the comparison of MTA vs. Ca(OH)2 and moderate-certainty evidence for the comparison of Biodentine vs. Ca(OH)2. In contrast, the comparisons of calcium silicate materials were frequently overlapped in their credible intervals with moderate certainty evidence; thus, no explicit difference was found between the calcium silicate materials (e.g., MTA & Biodentine). If adjunctive therapies (e.g., platelet-rich plasma & laser therapies) have a promising effect on success rates, they were supported with low-certainty evidence based on limited data and network sparsity. The meta-analysis met the requirement for network coherence (p > 0.10) and the amount of heterogeneity found was low (τ2 = 0.09). Vital pulp therapy in mature permanent teeth demonstrates consistently high success rates, particularly when using calcium silicate-based materials. These findings are supported by high-certainty evidence for comparisons with calcium hydroxide. However, differences among calcium silicate materials remain uncertain due to overlapping credible intervals and moderate certainty of evidence, while adjunctive therapies are supported by low-certainty evidence and should be interpreted cautiously. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251074110, PROSPERO CRD420251074110.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.